How has the analytics and consulting market scenario changed
over time?
Analytical capabilities have improved considerably over time. Today, it
is used in some form or other by most of the companies to gain competitive edge
over the others in the similar way companies used IT in 80s & 90s.
Increasing data sources and availability of different types of data has
triggered the need to utilize it to our advantage. As analytics become essential
for all business, the industry will see tremendous growth in years to come.
marketRx of course, expects to grow as part of the growing industry.
How is marketRx different from its competitors?
marketRx has adopted a global product-enabled services model. That means we are
able to capture our expertise and knowledge into processes and tools that solve
pharmaceutical and biotech commercialization and promotion management problems
globally, and with significantly better results than pure-play services
companies. The company has developed analytical models and processes to help
these companies to maintain their competitive edge and improve ROI from their
sales and marketing initiatives. The key differentiator for marketRx is our
commitment to invest heavyly in innovation and R&D efforts to produce
state-o-the-art software products and services.
What are the company's growth plans in terms of investment,
employees and solutions provided?
As of now, we are looking at only organic growth and will continue to invest
heavily in our R&D efforts to innovate and provide our customers best
business solution along with expanding our solution base. We are driven by the
quest to maintain our leadership in the high-end marketing analytics services
segment. We have a dedicated R&D team to come up with sophisticated
analytical solutions incorporating statistical optimization modeling techniques.
We will continue that quest in our US, UK and India operations diligently.
Pragati Simlote, CyberMedia
News
maildqindia@cybermedia.co.in